From: A lipidomic approach to the study of human CD4+ T lymphocytes in multiple sclerosis
Fatty acids | HC | MS |
---|---|---|
14:0 | 1.5 ± 0.6 | 1.9 ± 0.7 |
16:0 | 34.3 ± 1.2 | 31.8 ± 2.0 |
16:1 | 0.2 ± 0.08 | 0.3 ± 0.09 |
18:0 | 57.2 ± 1.2 | 54.2 ± 4.0 |
18:1n-9 | 3.1 ± 0.5 | 5.6 ± 1.7* |
18:1n-11 | 0.7 ± 0.06 | 0.9 ± 0.08** |
18:2n-6 | 1.4 ± 0.2 | 2.0 ± 0.7 |
18:3n-3 | 0.5 ± 0.03 | 0.3 ± 0.01** |
20:4n-6 | 1.5 ± 0.1 | 4.4 ± 0.2** |
Σ SFA | 92.9 ± 0.6 | 86.9 ± 4.3*** |
Σ MUFA | 3.3 ± 0.2 | 5.8 ± 1.7*** |
Σ PUFA | 3.3 ± 0.4 | 6.7 ± 0.9** |
Total n-6 | 2.8 ± 0.9 | 6.4 ± 0.3** |
SFA/PUFA | 14.4 ± 1.7 | 7.9 ± 3.8*** |
UI | 13.7 ± 3.2 | 29.1 ± 11.6*** |